Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07390123 |
| Consolidated Lead Sponsor | Haisco Pharmaceutical Group Co |
| Therapeutic Condition Cohort | Gastroenterology, Hepatology, and Renal |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 370 participants (ESTIMATED) |
| Registered Start Date | 2026-04-07 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Peking University First Hospital | Beijing, China | Open Hospital Dossier -> |
| Xiangya Hospital of Central South University | Changsha, China | Open Hospital Dossier -> |
| The Second Hospital of Jilin University | Changchun, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.